7 Top M&A Highlights of Q3

Mergers & acquisitions took off in the third quarter with some eye-popping and historic buyouts

      View All  


Amgen 185 7 Top M&A Highlights of Q3One of the quarter’s largest deals went down in the biotechnology sector. Amgen (AMGN), the largest biotech company by sales, scooped up smaller rival Onyx Pharmaceuticals (ONXX) for $10.4 billion.

Onyx specializes in cancer-fighting drugs, and that’s what piqued Amgen’s interest — especially Kyprolis, a therapy for multiple myeloma.

Article printed from InvestorPlace Media, http://investorplace.com/2013/09/mergers-acquisitions-ma-q3-third-quarter/.

©2015 InvestorPlace Media, LLC

Comments are currently unavailable. Please check back soon.